ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFlux de trésorerie liés aux activités d'investissement-97 K-314 K-12 K17 K-325 K-114 K-434 KFlux de trésorerie liés aux activités de financement5.92 M10.69 M5.3 M1.66 M77.52 M745 K85.22 MFlux de trésorerie disponible-18.78 M-19.12 M-20.27 M-15.27 M-11.27 M-11.96 M-58.77 M
Precision BioSciences, Inc. - Common Stock
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.